Pharma 2029 Strategies
This article was originally published in RPM Report
The pharmaceutical industry is facing major problems today that require complex solutions. But drug companies are in danger of losing their most forward-thinking and capable strategists at a time when they're needed most.
You may also be interested in...
Health care reform advocates think the stars are aligned for a major push toward universal coverage under President-elect Barack Obama. They aren’t about to let the free-falling economy get in the way.
The Reagan-Udall Foundation is an early priority for FDA in implementing the landmark legislation enacted by Congress in 2007. It is also a lightning road for criticism from Congress about the agency's relationship with regulated industry. We asked foundation chairman Mark McClellan for a status report.